CN112384076A - 用于增强甜度的女贞甙酸及其衍生物 - Google Patents
用于增强甜度的女贞甙酸及其衍生物 Download PDFInfo
- Publication number
- CN112384076A CN112384076A CN201980046108.5A CN201980046108A CN112384076A CN 112384076 A CN112384076 A CN 112384076A CN 201980046108 A CN201980046108 A CN 201980046108A CN 112384076 A CN112384076 A CN 112384076A
- Authority
- CN
- China
- Prior art keywords
- rebaudioside
- acid
- sweetness
- effective amount
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002253 acid Substances 0.000 title claims abstract description 52
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 20
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 claims abstract description 35
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 claims abstract description 34
- 239000003607 modifier Substances 0.000 claims abstract description 25
- 241000219173 Carica Species 0.000 claims description 49
- 239000000796 flavoring agent Substances 0.000 claims description 44
- 239000000284 extract Substances 0.000 claims description 34
- 235000009467 Carica papaya Nutrition 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 29
- 229930006000 Sucrose Natural products 0.000 claims description 24
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 24
- 239000005720 sucrose Substances 0.000 claims description 22
- -1 galactosyl stevioside Chemical compound 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 235000003599 food sweetener Nutrition 0.000 claims description 12
- 235000019202 steviosides Nutrition 0.000 claims description 12
- 239000003765 sweetening agent Substances 0.000 claims description 12
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 11
- 229940013618 stevioside Drugs 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 10
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 10
- RPYRMTHVSUWHSV-CUZJHZIBSA-N rebaudioside D Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RPYRMTHVSUWHSV-CUZJHZIBSA-N 0.000 claims description 10
- 235000002639 sodium chloride Nutrition 0.000 claims description 10
- 235000019605 sweet taste sensations Nutrition 0.000 claims description 10
- 229930091371 Fructose Natural products 0.000 claims description 9
- 239000005715 Fructose Substances 0.000 claims description 9
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 8
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 8
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 8
- 235000013355 food flavoring agent Nutrition 0.000 claims description 8
- 235000021096 natural sweeteners Nutrition 0.000 claims description 7
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 6
- 244000185386 Thladiantha grosvenorii Species 0.000 claims description 6
- QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 claims description 6
- 108010011485 Aspartame Proteins 0.000 claims description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 5
- 239000001512 FEMA 4601 Substances 0.000 claims description 5
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 claims description 5
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 claims description 5
- 239000008122 artificial sweetener Substances 0.000 claims description 5
- 235000021311 artificial sweeteners Nutrition 0.000 claims description 5
- 239000000605 aspartame Substances 0.000 claims description 5
- 235000010357 aspartame Nutrition 0.000 claims description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 5
- 229960003438 aspartame Drugs 0.000 claims description 5
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 claims description 5
- 235000019203 rebaudioside A Nutrition 0.000 claims description 5
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 claims description 5
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 claims description 4
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 claims description 4
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 4
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- CANAPGLEBDTCAF-UHFFFAOYSA-N dulcoside a Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC23C(CC4(C2)C(C2(C)C(C(CCC2)(C)C(=O)OC2C(C(O)C(O)C(CO)O2)O)CC4)CC3)=C)OC(CO)C(O)C1O CANAPGLEBDTCAF-UHFFFAOYSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 claims description 4
- 235000019204 saccharin Nutrition 0.000 claims description 4
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 4
- 229940081974 saccharin Drugs 0.000 claims description 4
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 4
- 235000010436 thaumatin Nutrition 0.000 claims description 4
- 239000000892 thaumatin Substances 0.000 claims description 4
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 claims description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 229930186291 Dulcoside Natural products 0.000 claims description 3
- 239000004386 Erythritol Substances 0.000 claims description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 3
- 239000001776 FEMA 4720 Substances 0.000 claims description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 3
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 239000004384 Neotame Substances 0.000 claims description 3
- RLLCWNUIHGPAJY-RYBZXKSASA-N Rebaudioside E Natural products O=C(O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)[C@@H](O)[C@@H](O)[C@H](CO)O1)[C@]1(C)[C@@H]2[C@@](C)([C@@H]3[C@@]4(CC(=C)[C@@](O[C@@H]5[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O6)[C@H](O)[C@@H](O)[C@H](CO)O5)(C4)CC3)CC2)CCC1 RLLCWNUIHGPAJY-RYBZXKSASA-N 0.000 claims description 3
- OMHUCGDTACNQEX-OSHKXICASA-N Steviolbioside Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OMHUCGDTACNQEX-OSHKXICASA-N 0.000 claims description 3
- 239000004376 Sucralose Substances 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 3
- 229960004998 acesulfame potassium Drugs 0.000 claims description 3
- 239000000619 acesulfame-K Substances 0.000 claims description 3
- JLPRGBMUVNVSKP-AHUXISJXSA-M chembl2368336 Chemical compound [Na+].O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C([O-])=O)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O JLPRGBMUVNVSKP-AHUXISJXSA-M 0.000 claims description 3
- 235000019414 erythritol Nutrition 0.000 claims description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 3
- 229940009714 erythritol Drugs 0.000 claims description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 3
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 3
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- 235000019534 high fructose corn syrup Nutrition 0.000 claims description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 3
- 229960000367 inositol Drugs 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 229960001855 mannitol Drugs 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 229930191869 mogroside IV Natural products 0.000 claims description 3
- OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 claims description 3
- WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 claims description 3
- 235000019412 neotame Nutrition 0.000 claims description 3
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 3
- 108010070257 neotame Proteins 0.000 claims description 3
- RLLCWNUIHGPAJY-SFUUMPFESA-N rebaudioside E Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RLLCWNUIHGPAJY-SFUUMPFESA-N 0.000 claims description 3
- QRGRAFPOLJOGRV-UHFFFAOYSA-N rebaudioside F Natural products CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(CO)C(O)C(OC6OCC(O)C(O)C6O)C5OC7OC(CO)C(O)C(O)C7O)C(=O)OC8OC(CO)C(O)C(O)C8O QRGRAFPOLJOGRV-UHFFFAOYSA-N 0.000 claims description 3
- HYLAUKAHEAUVFE-AVBZULRRSA-N rebaudioside f Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)CO1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HYLAUKAHEAUVFE-AVBZULRRSA-N 0.000 claims description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 3
- 229930190082 siamenoside Natural products 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 229960002920 sorbitol Drugs 0.000 claims description 3
- 235000010356 sorbitol Nutrition 0.000 claims description 3
- 235000019408 sucralose Nutrition 0.000 claims description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 3
- DRSKVOAJKLUMCL-MMUIXFKXSA-N u2n4xkx7hp Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DRSKVOAJKLUMCL-MMUIXFKXSA-N 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- VMRGPCWYQLQNRB-ZHRVIQQSSA-N [(2S,3R,4S,5S,6R)-6-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate Chemical compound C[C@@]12CCC[C@](C)([C@H]1CC[C@@]13CC(=C)[C@@](C1)(CC[C@@H]23)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)O[C@@H]1O[C@H](CO[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@H]1O VMRGPCWYQLQNRB-ZHRVIQQSSA-N 0.000 claims 2
- 235000001727 glucose Nutrition 0.000 claims 2
- 241000735234 Ligustrum Species 0.000 description 36
- 235000014649 Carica monoica Nutrition 0.000 description 22
- 229960004793 sucrose Drugs 0.000 description 22
- 235000019634 flavors Nutrition 0.000 description 21
- 239000000047 product Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 14
- 239000000419 plant extract Substances 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 244000228451 Stevia rebaudiana Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 235000013618 yogurt Nutrition 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 239000003623 enhancer Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 241000830535 Ligustrum lucidum Species 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 235000012174 carbonated soft drink Nutrition 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 240000006432 Carica papaya Species 0.000 description 3
- 229940035676 analgesics Drugs 0.000 description 3
- 239000000730 antalgic agent Substances 0.000 description 3
- 239000002417 nutraceutical Substances 0.000 description 3
- 235000021436 nutraceutical agent Nutrition 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- QZOALWMSYRBZSA-PDSBIMDKSA-N (3r,5r,8r,9r,10r,13s,14r)-3-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-[(1s)-1-[(2r,5s,6r)-5-methyl-6-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1C[C@H]2C(=O)C[C@@H]3[C@H]4CCC([C@]4(CC[C@H]3[C@@]2(C)CC1)C)[C@H](C)[C@@H]1O[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](C)CC1)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O QZOALWMSYRBZSA-PDSBIMDKSA-N 0.000 description 2
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- SLAOFBPSPQHAJS-UHFFFAOYSA-N 3-(4-hydroxycyclohexa-2,4-dien-1-yl)-1-phenylprop-2-en-1-one Chemical compound C1=CC(O)=CCC1C=CC(=O)C1=CC=CC=C1 SLAOFBPSPQHAJS-UHFFFAOYSA-N 0.000 description 2
- NNXQSUSEFPRCRS-YCKMUKMSSA-N 3-[(3S,3aR,4R,5aR,6S,7S,9aR,9bR)-3-[(E,2S)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-prop-1-en-2-yl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,3a,4,5,5a,7,8,9-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1[C@@H]2[C@@H]([C@@](C)(O)C\C=C\C(C)(C)O)CC[C@@]2(C)[C@]2(C)CC[C@@H](C(C)=C)[C@](C)(CCC(O)=O)[C@H]2C1 NNXQSUSEFPRCRS-YCKMUKMSSA-N 0.000 description 2
- 241000208140 Acer Species 0.000 description 2
- 241000954177 Bangana ariza Species 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 241000234653 Cyperus Species 0.000 description 2
- 244000075634 Cyperus rotundus Species 0.000 description 2
- 235000016854 Cyperus rotundus Nutrition 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- FNMHEHXNBNCPCI-QEOJJFGVSA-N Isoacteoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](OCCC=2C=C(O)C(O)=CC=2)O[C@H](COC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@H]1O FNMHEHXNBNCPCI-QEOJJFGVSA-N 0.000 description 2
- 241000201320 Ligustrum japonicum Species 0.000 description 2
- 241001108829 Ligustrum quihoui Species 0.000 description 2
- 108050004114 Monellin Proteins 0.000 description 2
- 241000795633 Olea <sea slug> Species 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 235000002725 Olea europaea Nutrition 0.000 description 2
- QZOALWMSYRBZSA-UHFFFAOYSA-N Osladin Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O QZOALWMSYRBZSA-UHFFFAOYSA-N 0.000 description 2
- 101000865553 Pentadiplandra brazzeana Defensin-like protein Proteins 0.000 description 2
- DYWNLSQWJMTVGJ-KUSKTZOESA-N Phenylpropanolamine hydrochloride Chemical compound Cl.C[C@H](N)[C@H](O)C1=CC=CC=C1 DYWNLSQWJMTVGJ-KUSKTZOESA-N 0.000 description 2
- 229940126902 Phlorizin Drugs 0.000 description 2
- 241001672981 Purpura Species 0.000 description 2
- 206010037549 Purpura Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 229940069428 antacid Drugs 0.000 description 2
- 239000003159 antacid agent Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003793 antidiarrheal agent Substances 0.000 description 2
- 229940125714 antidiarrheal agent Drugs 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 229940125716 antipyretic agent Drugs 0.000 description 2
- 239000003434 antitussive agent Substances 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 235000014510 cooky Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 108010010165 curculin Proteins 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 229940066493 expectorants Drugs 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 2
- 229960001587 hesperetin Drugs 0.000 description 2
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 2
- 235000010209 hesperetin Nutrition 0.000 description 2
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- FNMHEHXNBNCPCI-RYEKTNFUSA-N isoacteoside Natural products C[C@@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](COC(=O)C=Cc3ccc(O)c(O)c3)O[C@@H](OCCc4ccc(O)c(O)c4)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O FNMHEHXNBNCPCI-RYEKTNFUSA-N 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 229940125722 laxative agent Drugs 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 229960002305 phenylpropanolamine hydrochloride Drugs 0.000 description 2
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 2
- IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 description 2
- 235000019139 phlorizin Nutrition 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- NNXQSUSEFPRCRS-UHFFFAOYSA-N pterocaryoside A Natural products OC1C(O)C(O)C(C)OC1OC1C2C(C(C)(O)CC=CC(C)(C)O)CCC2(C)C2(C)CCC(C(C)=C)C(C)(CCC(O)=O)C2C1 NNXQSUSEFPRCRS-UHFFFAOYSA-N 0.000 description 2
- SODWWCZKQRRZTG-UHFFFAOYSA-N pterocaryoside B Natural products OC(=O)CCC1(C)C(C(=C)C)CCC(C2(CCC(C22)C(C)(O)CC=CC(C)(C)O)C)(C)C1CC2OC1OCC(O)C(O)C1O SODWWCZKQRRZTG-UHFFFAOYSA-N 0.000 description 2
- 229940125723 sedative agent Drugs 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- KDSWDGKIENPKLB-QJDQKFITSA-N verbascoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)CCC=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O KDSWDGKIENPKLB-QJDQKFITSA-N 0.000 description 2
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- CAVQBDOACNULDN-NRCOEFLKSA-N (1s,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric acid Chemical compound OS(O)(=O)=O.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 CAVQBDOACNULDN-NRCOEFLKSA-N 0.000 description 1
- RDEIXVOBVLKYNT-HDZPSJEVSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-[(1r)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2 Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)[C@@H](C)N)N)[C@@H](N)C[C@H]1N.O1[C@H]([C@@H](C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-HDZPSJEVSA-N 0.000 description 1
- GRWRKEKBKNZMOA-SJJZSDDKSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O GRWRKEKBKNZMOA-SJJZSDDKSA-N 0.000 description 1
- YKFCISHFRZHKHY-NGQGLHOPSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;trihydrate Chemical compound O.O.O.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 YKFCISHFRZHKHY-NGQGLHOPSA-N 0.000 description 1
- YQSHYGCCYVPRDI-UHFFFAOYSA-N (4-propan-2-ylphenyl)methanamine Chemical compound CC(C)C1=CC=C(CN)C=C1 YQSHYGCCYVPRDI-UHFFFAOYSA-N 0.000 description 1
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- BCXHDORHMMZBBZ-DORFAMGDSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;sulfuric acid Chemical compound OS(O)(=O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC BCXHDORHMMZBBZ-DORFAMGDSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- WFXURHIXPXVPGM-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;2-methyl-9-phenyl-1,3,4,9-tetrahydroindeno[2,1-c]pyridine Chemical compound OC(=O)C(O)C(O)C(O)=O.C1N(C)CCC(C2=CC=CC=C22)=C1C2C1=CC=CC=C1 WFXURHIXPXVPGM-UHFFFAOYSA-N 0.000 description 1
- CWWCQGGNKDBSNT-UHFFFAOYSA-N 2-(2-phenoxyphenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC=C1OC1=CC=CC=C1 CWWCQGGNKDBSNT-UHFFFAOYSA-N 0.000 description 1
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- VCCNKWWXYVWTLT-CYZBKYQRSA-N 7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chromen-4-one Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 VCCNKWWXYVWTLT-CYZBKYQRSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- IXVMHGVQKLDRKH-VRESXRICSA-N Brassinolide Natural products O=C1OC[C@@H]2[C@@H]3[C@@](C)([C@H]([C@@H]([C@@H](O)[C@H](O)[C@H](C(C)C)C)C)CC3)CC[C@@H]2[C@]2(C)[C@@H]1C[C@H](O)[C@H](O)C2 IXVMHGVQKLDRKH-VRESXRICSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 229920001268 Cholestyramine Polymers 0.000 description 1
- JCBOLGTUBPEJOE-UHFFFAOYSA-N Cl.ClC1=CC=CS1 Chemical compound Cl.ClC1=CC=CS1 JCBOLGTUBPEJOE-UHFFFAOYSA-N 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- KBAUFVUYFNWQFM-UHFFFAOYSA-N Doxylamine succinate Chemical compound OC(=O)CCC(O)=O.C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 KBAUFVUYFNWQFM-UHFFFAOYSA-N 0.000 description 1
- 239000004097 EU approved flavor enhancer Substances 0.000 description 1
- 239000001689 FEMA 4674 Substances 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 235000021559 Fruit Juice Concentrate Nutrition 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 241000246499 Gentiana acaulis Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- HYQNKKAJVPMBDR-HIFRSBDPSA-N Hernandulcin Chemical compound CC(C)=CCC[C@](C)(O)[C@@H]1CCC(C)=CC1=O HYQNKKAJVPMBDR-HIFRSBDPSA-N 0.000 description 1
- HYQNKKAJVPMBDR-UHFFFAOYSA-N Hernandulcin Natural products CC(C)=CCCC(C)(O)C1CCC(C)=CC1=O HYQNKKAJVPMBDR-UHFFFAOYSA-N 0.000 description 1
- 101000801619 Homo sapiens Long-chain-fatty-acid-CoA ligase ACSBG1 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001019 Inborn Errors Metabolism Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241000339411 Jarilla heterophylla Species 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000217086 Ligustrum amurense Species 0.000 description 1
- 241000629404 Ligustrum gracile Species 0.000 description 1
- 241000673684 Ligustrum liukiuense Species 0.000 description 1
- 241000576409 Ligustrum sinense Species 0.000 description 1
- 102100033564 Long-chain-fatty-acid-CoA ligase ACSBG1 Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- 241001257583 Microphyllum Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- KEECCEWTUVWFCV-UHFFFAOYSA-N N-acetylprocainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(NC(C)=O)C=C1 KEECCEWTUVWFCV-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 1
- NCHHVLCKEUNWNJ-IOJVUJSNSA-N O[C@H]([C@@H](O)C(O)=O)C(O)=O.C[C@H](N)[C@H](O)c1ccccc1 Chemical compound O[C@H]([C@@H](O)C(O)=O)C(O)=O.C[C@H](N)[C@H](O)c1ccccc1 NCHHVLCKEUNWNJ-IOJVUJSNSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- DLUTTXMPJCVUFR-HJCIYZGTSA-N Parillin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1C[C@H]2CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(OC[C@@H](C)CC1)O5)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DLUTTXMPJCVUFR-HJCIYZGTSA-N 0.000 description 1
- 241000598137 Pedunculus Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- SSOXZAQUVINQSA-BTJKTKAUSA-N Pheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=CC=C1 SSOXZAQUVINQSA-BTJKTKAUSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 201000011252 Phenylketonuria Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- OFFJUHSISSNBNT-UHFFFAOYSA-N Polypodoside A Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2=CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O OFFJUHSISSNBNT-UHFFFAOYSA-N 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 241001240958 Pseudomonas aeruginosa PAO1 Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 101150046432 Tril gene Proteins 0.000 description 1
- 229930182647 Trilobatin Natural products 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000050662 Vasconcellea cauliflora Species 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 208000029650 alcohol withdrawal Diseases 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 229940002273 anbesol Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000001539 anorectic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000002991 anti-hyperkinetic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002255 antigout agent Substances 0.000 description 1
- 229960002708 antigout preparations Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- JOKKBOSZTVHKSH-UHFFFAOYSA-N baiyunoside Natural products CC12CCC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)CO3)O)C(C)(C)C1CCC(C)=C2CCC=1C=COC=1 JOKKBOSZTVHKSH-UHFFFAOYSA-N 0.000 description 1
- 235000012820 baking ingredients and mixes Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 125000002351 beta-D-glucopyranosyloxy group Chemical group 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- IXVMHGVQKLDRKH-KNBKMWSGSA-N brassinolide Chemical compound C1OC(=O)[C@H]2C[C@H](O)[C@H](O)C[C@]2(C)[C@H]2CC[C@]3(C)[C@@H]([C@H](C)[C@@H](O)[C@H](O)[C@@H](C)C(C)C)CC[C@H]3[C@@H]21 IXVMHGVQKLDRKH-KNBKMWSGSA-N 0.000 description 1
- SRGKFVAASLQVBO-BTJKTKAUSA-N brompheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Br)C=C1 SRGKFVAASLQVBO-BTJKTKAUSA-N 0.000 description 1
- 229960003108 brompheniramine maleate Drugs 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 235000010634 bubble gum Nutrition 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 229960003871 codeine sulfate Drugs 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 235000015142 cultured sour cream Nutrition 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 229940124581 decongestants Drugs 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 229960003782 dextromethorphan hydrobromide Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- 229960005234 diphenoxylate hydrochloride Drugs 0.000 description 1
- 150000004662 dithiols Chemical class 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 229960005008 doxylamine succinate Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 229960001903 ergotamine tartrate Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- IVJISJACKSSFGE-UHFFFAOYSA-N formaldehyde;1,3,5-triazine-2,4,6-triamine Chemical compound O=C.NC1=NC(N)=NC(N)=N1 IVJISJACKSSFGE-UHFFFAOYSA-N 0.000 description 1
- 230000005089 fruit drop Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229960002146 guaifenesin Drugs 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940077716 histamine h2 receptor antagonists for peptic ulcer and gord Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- ZQDWXGKKHFNSQK-UHFFFAOYSA-N hydroxyzine Chemical compound C1CN(CCOCCO)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZQDWXGKKHFNSQK-UHFFFAOYSA-N 0.000 description 1
- 229960000930 hydroxyzine Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 208000016245 inborn errors of metabolism Diseases 0.000 description 1
- 208000015978 inherited metabolic disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229960001571 loperamide Drugs 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 235000020162 malted milk drink Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000000051 modifying effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 210000001577 neostriatum Anatomy 0.000 description 1
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229960004708 noscapine Drugs 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- XNLFIERPGXTDDP-UHFFFAOYSA-N periandrin i Chemical compound C1CC(C2C(C3(CCC4(C)CCC(C)(C=C4C3CC2)C(O)=O)C)(C)CC2)(C=O)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O XNLFIERPGXTDDP-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960003956 phenindamine tartrate Drugs 0.000 description 1
- 229960001339 pheniramine maleate Drugs 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960003733 phenylephrine hydrochloride Drugs 0.000 description 1
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 description 1
- 229960004401 phenylpropanolamine bitartrate Drugs 0.000 description 1
- 229960002790 phenytoin sodium Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- ODGAOXROABLFNM-UHFFFAOYSA-N polynoxylin Chemical compound O=C.NC(N)=O ODGAOXROABLFNM-UHFFFAOYSA-N 0.000 description 1
- 150000003085 polypodoside A derivatives Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 229960004159 pseudoephedrine sulfate Drugs 0.000 description 1
- 230000001003 psychopharmacologic effect Effects 0.000 description 1
- 229930185946 pterocaryoside Natural products 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 1
- 229930183111 sapindoside Natural products 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- FJPYVLNWWICYDW-UHFFFAOYSA-M sodium;5,5-diphenylimidazolidin-1-ide-2,4-dione Chemical compound [Na+].O=C1[N-]C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 FJPYVLNWWICYDW-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 150000008144 steviol glycosides Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 235000015149 toffees Nutrition 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000005918 transglycosylation reaction Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/12—Natural spices, flavouring agents or condiments; Extracts thereof from fruit, e.g. essential oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/88—Taste or flavour enhancing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/12—Natural spices, flavouring agents or condiments; Extracts thereof from fruit, e.g. essential oils
- A23L27/13—Natural spices, flavouring agents or condiments; Extracts thereof from fruit, e.g. essential oils from citrus fruits
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Seasonings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供了女贞甙酸或其衍生物用于增强甜味改性剂的甜度以及用于减少消费品中甜味改性剂的用量的用途。
Description
发明背景
降低食品和饮料中的糖含量已成为食品工业中的必然要求。食品和饮料制造商通常使用无热量的高强度甜度改性剂,例如莱鲍迪苷A(Reb A)、阿斯巴甜、糖精、糖基化的甜菊醇糖苷等来部分或完全替代糖。但是,这些甜度改性剂可能表现出不良的味觉属性,例如甜味的延迟发作、苦和涩的余味以及缺乏丰满感和口感。因此,甜味增强剂已成为有价值的工具,其减少糖和/或甜度改性剂的使用,以实现所需的甜度强度和口感,同时减少异味。
现有技术已描述了甜味增强剂。例如,WO 2013/143822教导了腺苷作为某些糖的甜味增强剂的用途;EP 2606747描述了脱氧胆酸或其衍生物用于增强消费品的甜度的用途;WO 2013/077668描述了衍生自豆酱的聚糖或糖肽的甜味增强效果;WO 2012/107203教导了川皮苷或其衍生物或水合物作为甜味剂或甜味增强剂的用途;WO 2009/023975描述了异罗汉果苷V作为甜味剂和甜味增强剂的用途;US 2008/0242740教导了用于增强甜味感的烷酰胺与橙皮素和/或4-羟基二氢查尔酮的芳香组合物;以及WO 2007/014879和WO 2007/107596分别教导了橙皮素和4-羟基二氢查尔酮用于增强甜味物质的甜度或调味剂的甜味嗅觉印象的用途。
发明内容
本发明提供了一种通过添加嗅觉有效量的女贞甙酸或其衍生物来增强甜味改性剂的甜度的方法。
女贞甙酸及其衍生物,2'-羟基女贞甙酸,由如下式所示:
在一个实施方案中,本发明涉及一种增强甜味改性剂的甜度的方法,包括添加嗅觉有效量的女贞甙酸或其衍生物的步骤。
在另一个实施方案中,本发明涉及增强甜味改性剂的甜度的方法,其包括添加嗅觉有效量的番木瓜(Carica papaya)叶提取物的步骤。
在另一个实施方案中,本发明涉及一种组合物,其包含甜味改性剂和嗅觉有效量的女贞甙酸或其衍生物。
在另一个实施方案中,本发明涉及一种组合物,其包含甜味改性剂和嗅觉有效量的番木瓜叶提取物。
在另一个实施方案中,本发明涉及一种消费品,其包含甜味改性剂和嗅觉有效量的女贞甙酸或其衍生物。
在另一个实施方案中,本发明涉及一种消费品,其包含甜味改性剂和嗅觉有效量的番木瓜叶提取物。
通过阅读说明书以下内容,本发明的这些和其他实施方案将变得显而易见。
发明详述
女贞甙酸,[3-(羧基亚甲基)-2-(β-D-吡喃葡萄糖基氧基)-3,4-二氢-5-(甲氧基羰基)]-2H-吡喃-4-乙酸-α-[2-(4-羟基苯基)乙基]酯,及其衍生物2'-羟基女贞甙酸是女贞(Ligustrum lucidum Ait.)和日本女贞(Ligustrum japonicum)的天然成分。在莎草属(Cyperus)和橄榄属(olive)中也报道了2'-羟基女贞甙酸(Li et al.,Molecules(2017),22(5):689;Gao et al.,Records of Natural Products(2015),9(3):323-328;Kikuchiet al.,Yakugaku Zasshi(1985),105(2):142-147;Gao et al.,Chemistry of NaturalCompounds(2017),53(3):553-554;Cheng et al.,Article in Asian Journal ofChemistry(2014),26(13):3967-3970;Rubio-Senent et al.,Journal of agriculturaland food chemistry(2013),61(6):1235-1248)。
女贞作为一种传统中药已经有数千年历史,可用于提振肝肾(Hu et al.,Oncology Reports(2014),32(3):1037-1042)。在欧洲、中国和日本,其他品种,如Ligustrum liukiuense、尖叶女贞(Ligustrum lucidum)、玉山女贞(Ligustrummorrisonense)、总梗女贞(Ligustrumpricei)和小蜡女贞(Ligustrum sinense)也被广泛用作茶或草药(Wu et al.Food Chemistry(2011),127(2),564-571)。还在铜绿假单胞菌PA01生物膜形成与硫酸庆大霉素的联合处理中评估了小蜡女贞的提取物(Yang etal.Journal of environmental biology(2013),34(2Spec No),451-457)。因此,已经提出但尚未证明2'-羟基女贞甙酸可能具有抗氧化功能(Gao et al.,Records ofNaturalProducts(2015),9(3):323-328;Gao et al.,Chemistry of Natural Compounds(2017),53(3):553-554)。但是,关于女贞甙酸的功能尚未见报道,甚至未提出。
在本发明中,在番木瓜(Carica)属中首次鉴定出了女贞甙酸和2’-羟基女贞甙酸。此外,还发现了女贞甙酸和2’-羟基女贞甙酸在食品中具有意想不到的有利用途。特别地,已发现女贞甙酸和2’-羟基女贞甙酸,其盐或它们的混合物可增强甜味改性剂的甜度而没有不期望的异味。
因此,本发明提供了一种使用女贞甙酸、2’-羟基女贞甙酸、其盐或它们的混合物来提高甜味改性剂的甜度并减少在消费品中使用的改性剂的量的方法。
术语“女贞甙酸或其衍生物”应理解为是指女贞甙酸、2’-羟基女贞甙酸、其盐或它们的混合物。
在本发明中,女贞甙酸和2’-羟基女贞甙酸是可商购的,并且也可以是植物提取物的分离和纯化的形式,例如女贞属(Ligustrum),如台湾女贞(Ligustrum amamianum)、Ligustrum amurense、狭叶女贞(Ligustrum angustum)、Ligustrum australianum、Ligustrum chenaultii、长叶女贞(Ligustrum compactum)、散生女贞(Ligustrumconfusum)、Ligustrum delavayanum、扩展女贞(Ligustrum expansum)、细女贞(Ligustrumgracile)丽叶女贞(Ligustrum henryi)、钝叶水蜡(Ligustrum ibota)、Ligustrumindicum、日本女贞(Ligustrumjaponicum)、蜡子树(Ligustrum leucanthum)、华女贞(Ligustrum lianum)、Ligustrum liukiuense、长筒女贞(Ligustrum longitubum)、尖叶女贞(Ligustrum lucidum)、Ligustrum massalongianum、Ligustrum micranthum、Ligustrummicrocarpum、玉山女贞(Ligustrum morrisonense)、倒卵叶女贞(Ligustrumobovatilimbum)、水蜡树(Ligustrum obtusifolium)、大叶女贞(Ligustrumovalifolium)、总梗女贞(Ligustrumpedunculare)、Ligustrum pricei、斑叶女贞(Ligustrum punctifolium)、小叶女贞(Ligustrum quihoui)、Ligustrum retusum、粗壮女贞(Ligustrum robustum)、裂果女贞(Ligustrum sempervirens)、Ligustrum sinense、宜昌女贞(Ligustrum strongylophyllum)、细梗女贞(Ligustrum tenuipes)、Ligustrumtschonoskii、普通女贞(Ligustrum vulgare)、兴仁女贞(Ligustrum xingrenense)和云贵女贞(Ligustrum yunguiense);莎草属(Cyperus),如香附(Cyperus rotundus)、木犀榄属(Olea)如油橄榄(Olea europaea);以及番木瓜属,如Carica baccata、Caricacandamarcensis、Carica candicans、Carica caudata、Carica cauliflora、Caricacestriflora、Carica chilensis、Carica crassipetala、Carica cundinamarcensis、Carica dodecaphylla、Carica glandulosa、Carica goudotiana、Carica heterophylla、Carica horovitziana、Carica longiflora、Carica Mexicana、Carica microcarpa、Carica monoica、Carica nana、Carica omnilingua、Carica palandensis、Caricaparviflora、Carica pentagona、柔毛番木瓜(Carica pubescens)、Caricapulchra、Caricaquercifolia、Carica sphaerocarpa、Carica spinose、Carica sprucei、Caricastipulate和Carica weberbaueri。盐形式例如包括女贞甙酸甲酯。
如果以植物提取物的形式提供,则优选提取物富含女贞甙酸和2’-羟基女贞甙酸,以分别达到约0.01%和更高的含量。例如,植物提取物包含的女贞甙酸和2’-羟基女贞甙酸分别为约0.05%至约95%,约0.1%至约50%或约0.2%至约10%。除非另有说明,否则百分比(%s)均以重量计。
天然甜味剂包括但不限于例如蔗糖、果糖、葡萄糖、高果糖玉米糖浆、包含Reb A、甜菊苷和莱鲍迪苷D(Reb D)的纯组分的甜叶菊组合物(Steviarebaudianacompositions)、木糖、阿拉伯糖或鼠李糖、以及糖醇,例如赤藓糖醇、木糖醇、甘露醇、山梨糖醇、肌醇及它们的组合。人造甜味剂包括但不限于例如阿斯巴甜、三氯蔗糖、纽甜、乙酰磺胺酸钾、糖精及它们的组合。
调味剂是向消费品提供特定的味道和/或气味的制剂。具有改性性质的调味剂是所述调味剂的子集。将其加入到消费品中,以减小异味和/或改善整体特征(overallprofile)。本发明的具有改性性质的调味剂包括但不限于,例如甜叶菊组合物(steviacomposition),包括甜菊苷、甜菊双糖苷Reb A、甜叶菊苷B(Reb B)、甜叶菊苷C(Reb C)、RebD、甜叶菊苷E(Reb E)、甜叶菊苷F(RebF)、杜克苷A(dulcoside A)、杜克苷B、甜叶悬钩子苷(rubusoside)、α-葡糖基甜菊糖(α-glucosyl stevia)、果糖基甜菊糖、半乳糖基甜菊糖、β-葡糖基甜菊糖、赛门苷、罗汉果苷IV、罗汉果苷V、罗汉果、莫纳甜(monatin)、甘草酸、索马甜(thaumatin)、其盐、其糖基化衍生物以及它们的组合。糖基化衍生物可通过与以下所列各项进行转糖基化反应来制备:例如但不限于葡萄糖、果糖、半乳糖、鼠李糖、核糖、甘露糖、阿拉伯糖、岩藻糖、麦芽糖、乳糖、蔗糖、芸香糖、山梨糖、木酮糖、核酮糖、rhammulose和木糖。在一个实施方案中,本发明的具有改性性质的调味剂包括Reb A、Reb C、甜叶悬钩子苷、RebD、罗汉果苷V、罗汉果、莫纳甜酸、其盐、其糖基化衍生物以及它们的组合。本发明的具有改性性质的调味剂的固有甜度弱。本发明的一些其它调味剂包括但不限于,例如仙茅甜蛋白(curculin)、莫内林(monellin)、马宾灵(mabinlin)、布拉齐因(brazzein)、hernandulcin、叶甜素(phyllodulcin)、菝葜苷(glycyphyllin)、根皮苷(phloridzin)、trilobtain、白元参甙(baiyunoside)、欧亚水龙骨甜素(osladin)、水龙骨皂苷A(polypodoside A)、枫杨皂苷A(pterocaryoside A)、枫杨皂苷B(pterocaryoside B)、无患子倍半萜苷(mukurozioside)、假秦艽苷I(phlomisoside I)、巴西甘草甜素I(periandrin I)、相思子三萜苷A(abrusoside A)、青钱柳苷I(cyclocarioside I)以及它们的组合。
因此,本发明的术语“甜味改性剂”是指包括上面说明的天然甜味剂和人造甜味剂或具有改性性质的调味剂的甜味剂。
术语“甜度”或“甜度强度”理解为个体(例如人)所观察到或感受到的甜味感觉的相对强度,或通过品尝者(taster)检测到的甜度的程度或量,例如根据American Societyfor Testing Materials,Special TechnicalPublication-434:“Manual on SensoryTesting Methods,”ASTM International,West Conshohocken,PA.(1996)中描述的程序在感官评价中使用的0(无)至8(非常强)的程度。
术语“嗅觉有效量”理解为用于与甜味改性剂组合的女贞甙酸或其衍生物的量,其中女贞甙酸或其衍生物增强了所述甜味改性剂的甜度。其嗅觉有效量可根据多种因素而变化,包括其它成分、它们的相对量和期望的嗅觉效果。可使用提供期望程度的甜味增强而不呈现异味的任何量的女贞甙酸或其衍生物。在某些实施方案中,所述嗅觉有效量以重量计为约1ppb至约1000ppm,优选按重量计约5ppb至约100ppm,更优选按重量计约10ppb至约10ppm。当以植物提取物如番木瓜叶提取物的形式使用时,嗅觉有效量的范围为按重量计约100ppb至约1000ppm,优选按重量计约1至约500ppm,更优选按重量计约5至约200ppm。
消费品包括例如食品(例如饮料)、甜味剂(例如天然甜味剂或人造甜味剂)、药物组合物、膳食补充剂、营养品、牙科卫生组合物和化妆品。消费品可进一步含有调味剂。
在一些实施方案中,消费品是食品,包括但不限于,例如水果、蔬菜、果汁、肉制品(例如火腿、培根和香肠)、蛋制品、果汁浓缩液、明胶和明胶状产品(例如果酱、果胶、蜜饯等)、奶制品(例如酸奶、冰淇淋、酸奶油以及冻果子露)、糖衣、糖浆(包括糖蜜)、玉米、小麦、黑麦、大豆、燕麦、水稻和大麦的产品、坚果仁和坚果产品、蛋糕、饼干、糖果(例如奶糖、口香糖、水果味滴剂和巧克力糖、泡泡糖、薄荷糖)、奶油、派和面包。在某些实施方案中,食品为饮料,包括但不限于,例如咖啡、茶、碳酸软饮料(例如COKE和PEPSI)、非碳酸软饮料和其它果汁饮料、运动饮料(例如GATORADE和酒精饮料(例如啤酒、葡萄酒和烈酒)。消费品还包括配制的产品包,例如粒状调味混料,当与水重构时提供非碳酸饮料、速溶布丁混料、速溶咖啡和茶、咖啡伴侣、麦乳精混料、宠物食物、家畜饲料、烟草和烘焙用途的材料(例如用于制备面包、饼干、蛋糕、烙饼、甜甜圈等的粉状烘焙混料)。消费品还包括含有少量或不含有蔗糖的节食或低卡路里食物和饮料。优选的消费品包括碳酸饮料。消费品进一步包括调味品(例如香草、香料和佐料),风味增强剂(例如味精,monosodium glutamate),饮食甜味剂(dietetic sweeteners)和液体甜味剂。
在其它实施方案中,消费品为药物组合物、膳食补充剂、营养食品、口腔卫生组合物或化妆品。优选的组合物为包含女贞甙酸或其衍生物、一种或多种药学可接受的赋形剂以及一种或多种发挥除甜味增强以外的生物效应的活性剂的药物组合物。这样的活性剂包括药物制剂和生物制剂,其具有不同于增强味道的活性。本领域中熟知这样的活性制剂(参见例如ThePhysician's Desk Reference)。可根据本领域中已知的方法,例如,如Remington's Pharmaceutical Sciences,Mack Publishing Co.,Easton,PA中描述,制备这样的组合物。在一个实施方案中,这种活性剂包括支气管扩张剂、减食欲剂、抗组胺药剂、营养补充剂、缓泻剂、镇痛剂、麻醉剂、抗酸剂、H2受体拮抗剂、抗胆碱能药剂、止泻药剂、缓和剂、镇咳药、抗呕吐药剂、抗微生物药剂、抗菌药剂、抗真菌药剂、抗病毒药剂、祛痰药剂、抗炎药剂、解热药剂及它们的混合物。在另一个实施方案中,活性剂选自退热剂和镇痛剂,例如布洛芬、对乙酰氨基酚或阿司匹林;缓泻剂,例如酚酞二辛基磺基琥珀酸钠;食欲抑制剂,例如安非他命、苯丙醇胺、苯丙醇胺盐酸盐;或咖啡因;抗酸剂,例如碳酸钙;抗哮喘药剂,例如茶碱;止泻药,例如盐酸地芬诺酯;抗胃肠胀气剂,例如二甲基硅油(simethecon);偏头痛药剂,例如酒石酸麦角胺;精神药理学药剂,例如氟哌啶醇;解痉药或镇静剂,例如苯巴比妥;抗高动力学药剂,例如甲基多巴或哌甲酯;镇静剂,例如苯二氮卓,羟嗪,甲磺酸盐或吩噻嗪;抗组胺药,例如阿司咪唑,马来酸氯苯那敏,马来酸吡啶胺,琥珀酸多西拉敏,马来酸溴苯那敏,柠檬酸苯托沙敏,盐酸氯环嗪,马来酸非尼拉敏或酒石酸苯茚胺;减充血剂,例如盐酸苯丙醇胺,盐酸脱氧肾上腺素,盐酸伪麻黄碱,硫酸伪麻黄碱,重酒石酸苯丙醇胺或麻黄碱;β-受体阻滞剂,例如普萘洛尔;戒酒剂,例如二硫龙;镇咳药,例如苯佐卡因,右美沙芬,右美沙芬氢溴酸盐,诺斯卡品,柠檬酸卡贝他汀和盐酸氯苯噻吩;氟补充剂,例如氟化钠;局部抗生素,例如四环素或克林霉素;皮质类固醇补充剂,例如泼尼松或泼尼松龙;抗痛风药剂,例如秋水仙碱或别嘌呤醇;抗癫痫药,例如苯妥英钠;抗脱水剂,例如电解质补充剂;防腐剂,例如氯化十六烷基吡啶;NSAID,例如对乙酰氨基酚,布洛芬,萘普生或其盐;胃肠道活性剂,例如洛哌丁胺和法莫替丁;生物碱,例如磷酸可待因,硫酸可待因或吗啡;微量元素补充剂,例如氯化钠,氯化锌,碳酸钙,氧化镁和其他碱金属盐和碱土金属盐;维生素;离子交换树脂,例如消胆胺,胆固醇抑制剂和降脂物质;抗心律失常药,例如N-乙酰普鲁卡因酰胺;和祛痰剂,例如愈创甘油醚。膳食补充剂或营养制品的实例包括,例如但不限于用于治疗营养缺乏、创伤、手术、克罗恩病、肾病、高血压、肥胖等的肠内营养产品,以促进运动表现、肌肉增强或一般健康或先天性代谢障碍(如苯丙酮尿症)。特别地,这种组合物可含有一种或多种具有苦味或金属味或余味的氨基酸。这些氨基酸包括例如但不限于,必需的氨基酸,例如亮氨酸、异亮氨酸、组氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、苏氨酸、色氨酸、酪氨酸和缬氨酸的L异构体。牙科卫生组合物是本领域已知的,包括例如但不限于牙膏、漱口水、牙菌斑冲洗剂、牙线、牙齿止痛剂(例如ANBESOL)等。在一个实施方案中,牙科卫生组合物包含一种天然甜味剂。在另一个实施方案中,牙科卫生组合物包含一种以上的天然甜味剂。在另一个实施方案中,牙科卫生组合物包括蔗糖和玉米糖浆,或蔗糖和阿斯巴甜。化妆品包括例如但不限于面霜、唇膏、唇彩等。用于本发明的其它合适的化妆品包括护唇膏,例如CHAPSTICK或BURT'S BEESWAX唇膏。
此外,本发明还提供了通过加入女贞甙酸或其衍生物来增强具有改性性质的调味品的甜度并降低调味品在消费品中的使用水平的方法。在一个实施方案中,本发明提供了包含嗅觉有效量的女贞甙酸或其衍生物以及减少的量的具有改性性质的调味品的消费品,以获得与当仅改性性质的调味品以传统的量单独使用时相同的甜度水平。在这方面,消费品中使用的具有改性性质的调味品的量可减少至少约10%、20%、30%、40%、50%、60%、70%、80%、90%或95%,从约60%至约99%,或从约20%至约50%。
如所表明的,女贞甙酸或其衍生物可作为甜味增强剂用在消费品中,其保持期望的甜度,但是包含较少量的天然甜味剂或人造甜味剂。例如,通过加入女贞甙酸或其衍生物可制造出甜度与已知的碳酸软饮料相同的改良的碳酸软饮料,但具有较低的糖含量。
其它材料也可与本发明的女贞甙酸或其衍生物共同使用,以封装和/或传递增强的风味。一些熟知的材料为,例如但不限于,聚合物、低聚体、其它非聚合物(例如表面活性剂、乳化剂、脂类(包括脂肪、蜡和磷脂、有机油、矿物油、矿脂、天然油脂)、定香剂、纤维、淀粉、糖类和固体表面材料(例如沸石和二氧化硅)。一些优选的聚合物包括聚丙烯酸酯、聚脲、聚氨酯、聚丙烯酰胺、聚酯、聚醚、聚酰胺、聚(丙烯酸酯-共-丙烯酰胺)、淀粉、二氧化硅、明胶和阿拉伯胶、藻酸盐、壳聚糖、聚丙交酯、聚(三聚氰胺-甲醛)、聚(脲-甲醛)或它们的组合。
作为本发明的具体实施方案提供以下内容。本发明的其它修改对本领域技术人员将是显而易见的。此类修改理解为在本发明的范围内。材料购自Aldrich化学品公司,除非另行表明。除非另行说明,本文中所用的所有百分比是重量百分比,ppm理解为表示每百万份的份数,L理解为升,mL理解为毫升,g理解为克,Kg理解为千克,mol理解为摩尔,mmol理解为毫摩尔,psig理解为每平方英寸的表压磅力,以及mmHg理解为汞(Hg)的毫米数(mm)。实施例中使用的IFF是指International Flavors&FragrancesInc.,纽约,NY,USA。
实施例I:测试样品的制备
购买了番木瓜叶提取物( Industries Inc.,加利福尼亚州,U.S.)。在不同批次中,鉴定出了女贞甙酸、2'-羟基女贞甙酸、毛蕊花糖苷和异毛蕊花糖苷,分别为~0.1-1%、~0.2-2%、~0.2-2%和~0.01-0.4%。使用高效液相色谱(HPLC)进行进一步分离,以提供~95%纯度的女贞甙酸。此外,购买了2'-羟基女贞甙酸。
实施例II:增强蔗糖的甜度
在水中制备蔗糖溶液(4%)。制备不同浓度的各个女贞甙酸和2'-羟基女贞甙酸的乙醇水溶液(50%)。分别以1和200ppm的浓度评估了女贞甙酸和2'-羟基女贞甙酸。两者都没有味道和气味。
添加了女贞甙酸和2'-羟基女贞甙酸的蔗糖溶液的风味情况报告如下:
女贞甙酸表现出特别强的作用。与蔗糖一起使用时,女贞甙酸可增强总的甜度、层次感和口感。2'-羟基女贞甙酸在增强甜度方面显示出强大的作用。
实施例III:增强罗汉果的甜度
在水(120ppm)中制备了罗汉果(Biovittoria Ltd.,新西兰)溶液。如上所述(实施例II)制备女贞甙酸和2'-羟基女贞甙酸溶液。添加了女贞甙酸和2'-羟基女贞甙酸的罗汉果溶液的风味情况报告如下:
女贞甙酸表现出特别强的作用。与罗汉果一起使用时,女贞甙酸可增强总的甜度、层次感和口感。2'-羟基女贞甙酸在增强甜度方面显示出强大的作用。
实施例IV:测试溶液的制备
考察了植物提取物如番木瓜叶提取物对甜度的影响。在乙醇水溶液(50%)中制备番木瓜叶提取物的溶液,以获得1至1000ppm的一系列浓度,该提取物包含女贞子酸(0.61%)、2'-羟基女贞子酸(0.62%)、毛蕊花糖苷(0.69%)和异毛蕊花糖苷(0.21%)。
如上所述(实施例II和III)制备蔗糖(4%)和罗汉果(120ppm)的溶液。另外,还在水中制备了果糖(3.4%)、Reb A(GLG Life Tech Corporation,加拿大)(90ppm)和GSG(葡糖基甜菊苷,GLG Life Tech Corporation,加拿大)(200ppm)的溶液。
评估了分别用番木瓜叶提取物对(i)蔗糖、(ii)罗汉果、(iii)果糖、(iv)RebA和(v)GSG的甜度的增强。在所有测试组中,番木瓜叶提取物均增强了甜度。
实施例V:通过植物提取物增强蔗糖甜度
评估了添加了各种量的番木瓜叶提取物的蔗糖溶液(4%)。风味情况如下:
番木瓜叶提取物从1ppm开始增强蔗糖口感,并且从10ppm开始增强蔗糖甜度。然而,在500ppm开始表现出不期望的异味。
实施例VI:通过植物提取物增强果糖甜度
评估了添加了各种量的番木瓜叶提取物的果糖溶液(3.4%)。风味情况如下:
番木瓜叶提取物提供了蔗糖样的风味情况。番木瓜叶提取物在所有测试水平下均增强了果糖的甜度、层次感和口感。但是,在500ppm处开始产生不期望的异味。
实施例VII:植物提取物增强罗汉果的甜度
评估了添加了各种量的番木瓜叶提取物的罗汉果溶液(120ppm)。风味情况如下:
样品 | 提取物(ppm) | 风味情况 |
1 | 0(基础) | 淡的甜味感觉 |
2 | 1 | 有一些口感 |
3 | 10 | 甜味呈现较早,持久的口感有助于抑制苦味 |
4 | 20 | 前期甜味,前期口感 |
5 | 50 | 宜人的甜度,较少挥之不去的苦味,口感有助于抑制异味 |
6 | 100 | 效果明显,更具蔗糖样,较少异味 |
7 | 200 | 异味开始呈现 |
8 | 500 | 更多异味开始压制甜度 |
9 | 1000 | 木质、树皮和涩感压制了甜度 |
番木瓜叶提取物提供了蔗糖样的风味情况。番木瓜叶提取物增强了罗汉果的甜度,掩盖了挥之不去的苦味。但是,在500ppm处开始产生不期望的异味。
实施例VIII:通过植物提取物增强RebA的甜度
评估了添加了各种量的番木瓜叶提取物的Reb A溶液(90ppm)。风味情况如下:
番木瓜叶提取物增强了Reb A的甜度和口感,并掩盖了挥之不去的苦味和异味。但是,在500ppm处开始产生不期望的异味。
实施例IX:植物提取物增强GSG的甜度
评估了添加了各种量的番木瓜叶提取物的GSG(葡糖基甜菊苷)溶液(200ppm)。风味情况如下:
样品 | 提取物(ppm) | 风味情况 |
1 | 0(基础) | 淡的甜味感觉 |
2 | 1 | 效果最小 |
3 | 10 | 对甜度效果非常微弱,更多口感 |
4 | 20 | 对甜度效果非常微弱,更多口感 |
5 | 50 | 更多甜度,明显增强的口感 |
6 | 100 | 增强的甜度和口感 |
7 | 200 | 具有糖味口感的枫糖浆样,涩感开始呈现 |
8 | 500 | 枫糖浆样,涩感 |
9 | 1000 | 木质和树皮味 |
番木瓜叶提取物增强了葡糖基甜菊苷的甜度和口感。但是,在500ppm处开始产生不期望的异味。
实施例X:增强含蔗糖的酸奶的甜度
制备了具有6%蔗糖的Dannon脱脂原味酸奶,并将其用作基础。将不同量的番木瓜叶提取物添加到基础中。评估了风味情况,结果如下:
番木瓜叶提取物增强了含蔗糖的酸奶的甜度,并降低了酸味。但是,在1000ppm处开始产生不期望的异味。
实施例XI:增强含GSG的酸奶的甜度
制备了具有GSG(600pm)的Dannon原味脱脂酸奶,并用作基础。将不同量的番木瓜叶提取物添加到基础中。评估了风味情况,结果如下:
番木瓜叶提取物增强了含有GSG的酸奶的甜度和口感。
实施例XII:增强含蔗糖的酸奶的甜度
将不同量的番木瓜叶提取物添加到Dannon Danimals Smoothies YogurtDrink(爆炸草莓,Strawberry Explosion)中,该饮料含9%的蔗糖(cane sugar)。评估了风味情况,结果如下:
番木瓜叶提取物在所有测试水平下均增强了含蔗糖(cane sugar)的酸奶的甜度和口感。
Claims (20)
1.一种增强甜味改性剂的甜度的方法,包括添加嗅觉有效量的女贞甙酸或其衍生物的步骤。
2.根据权利要求1所述的方法,其中所述甜味改性剂是甜味剂。
3.根据权利要求2所述的方法,其中所述甜味剂是选自以下的天然甜味剂:蔗糖、果糖、葡萄糖、高果糖玉米糖浆、莱鲍迪苷A、甜菊苷、莱鲍迪苷D、木糖、阿拉伯糖、鼠李糖、赤藓糖醇、木糖醇、甘露糖醇、山梨糖醇、肌醇及它们的组合。
4.根据权利要求2所述的方法,其中所述甜味剂是选自以下的人造甜味剂:阿斯巴甜、三氯蔗糖、纽甜、乙酰磺胺酸钾、糖精及它们的组合。
5.根据权利要求1所述的方法,其中所述甜味改性剂是选自以下所列具有改性性质的调味剂:甜菊苷、甜菊双糖苷莱鲍迪苷A、莱鲍迪苷B、莱鲍迪苷C、莱鲍迪苷D、莱鲍迪苷E、莱鲍迪苷F、杜克苷A、杜克苷B、甜叶悬钩子苷、α-葡糖基甜菊糖、果糖基甜菊糖、半乳糖基甜菊糖、β-葡萄糖基甜菊糖、赛门苷、罗汉果苷IV、罗汉果苷V、罗汉果、莫纳甜、甘草酸、索马甜、其盐、其糖基化衍生物及它们的组合。
6.根据权利要求1所述的方法,其中所述嗅觉有效量为约1ppb至约1000ppm。
7.根据权利要求1所述的方法,其中所述嗅觉有效量为约5ppb至约100ppm。
8.根据权利要求1所述的方法,其中所述嗅觉有效量为约10ppb至约10ppm。
9.根据权利要求1所述的方法,其中所述女贞甙酸或其衍生物以番木瓜叶提取物提供。
10.一种组合物,其包含甜味改性剂和嗅觉有效量的女贞甙酸或其衍生物。
11.根据权利要求10所述的组合物,其中所述甜味改性剂是甜味剂。
12.根据权利要求11所述的组合物,其中所述甜味剂是选自以下所列的天然甜味剂:蔗糖、果糖、葡萄糖、高果糖玉米糖浆、莱鲍迪苷A、甜菊苷、莱鲍迪苷D、木糖、阿拉伯糖、鼠李糖、赤藓糖醇、木糖醇、甘露糖醇、山梨糖醇、肌醇及它们的组合。
13.根据权利要求11所述的组合物,其中所述甜味剂是选自以下的人造甜味剂:阿斯巴甜、三氯蔗糖、纽甜、乙酰磺胺酸钾、糖精及它们的组合。
14.根据权利要求10所述的组合物,其中所述甜味改性剂是选自以下所列具有改性性质的调味剂:甜菊苷、甜菊双糖苷莱鲍迪苷A、莱鲍迪苷B、莱鲍迪苷C、莱鲍迪苷D、莱鲍迪苷E、莱鲍迪苷F、杜克苷A、杜克苷B、甜叶悬钩子苷、α-葡糖基甜菊糖、果糖基甜菊糖、半乳糖基甜菊糖、β-葡糖基甜菊糖、赛门苷、罗汉果苷IV、罗汉果苷V、罗汉果、莫纳甜、甘草酸、索马甜、其盐、其糖基化衍生物及它们的组合。
15.根据权利要求10所述的组合物,其中嗅觉有效量为约1ppb至约1000ppm。
16.根据权利要求10所述的组合物,其中嗅觉有效量为约5ppb至约100ppm。
17.根据权利要求10所述的组合物,其中嗅觉有效量为约10ppb至约10ppm。
18.根据权利要求10所述的组合物,其中所述女贞甙酸或其衍生物以番木瓜叶提取物提供。
19.一种消费品,其包含甜味改性剂和嗅觉有效量的女贞甙酸或其衍生物。
20.根据权利要求19所述的消费品,其中所述消费品是食品,并且其中所述女贞甙酸或其衍生物以番木瓜叶提取物提供。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862697008P | 2018-07-12 | 2018-07-12 | |
US62/697,008 | 2018-07-12 | ||
US201962813453P | 2019-03-04 | 2019-03-04 | |
US62/813,453 | 2019-03-04 | ||
PCT/US2019/041585 WO2020014601A1 (en) | 2018-07-12 | 2019-07-12 | Ligustrosidic acid and derivatives thereof for sweetness enhancement |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112384076A true CN112384076A (zh) | 2021-02-19 |
Family
ID=69141926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201980046108.5A Pending CN112384076A (zh) | 2018-07-12 | 2019-07-12 | 用于增强甜度的女贞甙酸及其衍生物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210251267A1 (zh) |
EP (1) | EP3820305A4 (zh) |
CN (1) | CN112384076A (zh) |
BR (1) | BR112021000310A2 (zh) |
MX (1) | MX2021000330A (zh) |
WO (1) | WO2020014601A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024007104A1 (zh) * | 2022-07-04 | 2024-01-11 | 国际香料和香精公司 | 用于增强甜味的新型吡喃葡萄糖苷组合物 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024026225A1 (en) | 2022-07-26 | 2024-02-01 | International Flavors & Fragrances Inc. | Robust flavor emulsions |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2003120913A (ru) * | 2003-07-08 | 2005-02-10 | Научно-исследовательский институт пищеконцентратной промышленности и специальной пищевой технологии (государственное научное учреждение) (RU) | Способ получения желейного мармелада |
US20080069907A1 (en) * | 2004-07-06 | 2008-03-20 | Chikao Morimoto | Compositions for Cancer Prevention, Treatment, or Amelioration Comprising Papaya Extract |
CN101784201A (zh) * | 2007-06-08 | 2010-07-21 | 奇华顿股份有限公司 | 消费品 |
CN101959427A (zh) * | 2008-02-25 | 2011-01-26 | 奇华顿股份有限公司 | 风味分子 |
CN102762111A (zh) * | 2009-12-28 | 2012-10-31 | 可口可乐公司 | 甜味增强剂,其组合物,及使用方法 |
KR101293687B1 (ko) * | 2012-12-20 | 2013-08-06 | 한아름영농조합법인 | 파파야 잎 차, 이의 추추물을 포함하는 기능성 차 음료, 및 이의 제조방법 |
CN103653238A (zh) * | 2012-09-17 | 2014-03-26 | 福建中烟工业有限责任公司 | 一种番木瓜叶提取液的制备方法及其在卷烟中的应用 |
JP2015038043A (ja) * | 2013-08-19 | 2015-02-26 | 幾夫 森本 | 免疫賦活化用組成物 |
KR20170032589A (ko) * | 2015-09-15 | 2017-03-23 | 하상섭 | 포포나무 추출물을 주성분으로 함유하는 음료의 제조방법 |
US20170333358A1 (en) * | 2016-05-18 | 2017-11-23 | Capsugel Belgium Nv | Separable capsule for sprinkling applications |
US20220046970A1 (en) * | 2018-07-12 | 2022-02-17 | International Flavors & Fragrances Inc. | Verbascoside and related compounds for sweetness enhancement |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2001448A2 (en) * | 2006-01-27 | 2008-12-17 | Cadbury Adams USA LLC | Flavor-enhancing compositions, methods of manufacture, and methods of use |
US20080014331A1 (en) * | 2006-07-17 | 2008-01-17 | Constantin Badalov | Super sweet sugar crystals and syrups for health and method |
US20110206786A1 (en) * | 2010-02-23 | 2011-08-25 | Brett Justin West | Acai and Iridoid Based Formulations |
MX369176B (es) * | 2012-06-04 | 2019-10-23 | Univ Autonoma Del Estado De Hidalgo Star | Composiciones fitoquímicas útiles como desinfectantes y conservadores para alimentos. |
JP6315767B2 (ja) * | 2013-12-10 | 2018-04-25 | 長谷川香料株式会社 | 果実風味飲食品用呈味改善剤 |
CN108473528A (zh) * | 2015-10-29 | 2018-08-31 | 赛诺米克斯公司 | 高强度甜味剂 |
-
2019
- 2019-07-12 BR BR112021000310-0A patent/BR112021000310A2/pt unknown
- 2019-07-12 US US17/259,307 patent/US20210251267A1/en active Pending
- 2019-07-12 EP EP19834367.5A patent/EP3820305A4/en active Pending
- 2019-07-12 WO PCT/US2019/041585 patent/WO2020014601A1/en unknown
- 2019-07-12 CN CN201980046108.5A patent/CN112384076A/zh active Pending
- 2019-07-12 MX MX2021000330A patent/MX2021000330A/es unknown
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2003120913A (ru) * | 2003-07-08 | 2005-02-10 | Научно-исследовательский институт пищеконцентратной промышленности и специальной пищевой технологии (государственное научное учреждение) (RU) | Способ получения желейного мармелада |
US20080069907A1 (en) * | 2004-07-06 | 2008-03-20 | Chikao Morimoto | Compositions for Cancer Prevention, Treatment, or Amelioration Comprising Papaya Extract |
CN101784201A (zh) * | 2007-06-08 | 2010-07-21 | 奇华顿股份有限公司 | 消费品 |
CN101959427A (zh) * | 2008-02-25 | 2011-01-26 | 奇华顿股份有限公司 | 风味分子 |
CN102762111A (zh) * | 2009-12-28 | 2012-10-31 | 可口可乐公司 | 甜味增强剂,其组合物,及使用方法 |
CN103653238A (zh) * | 2012-09-17 | 2014-03-26 | 福建中烟工业有限责任公司 | 一种番木瓜叶提取液的制备方法及其在卷烟中的应用 |
KR101293687B1 (ko) * | 2012-12-20 | 2013-08-06 | 한아름영농조합법인 | 파파야 잎 차, 이의 추추물을 포함하는 기능성 차 음료, 및 이의 제조방법 |
JP2015038043A (ja) * | 2013-08-19 | 2015-02-26 | 幾夫 森本 | 免疫賦活化用組成物 |
KR20170032589A (ko) * | 2015-09-15 | 2017-03-23 | 하상섭 | 포포나무 추출물을 주성분으로 함유하는 음료의 제조방법 |
US20170333358A1 (en) * | 2016-05-18 | 2017-11-23 | Capsugel Belgium Nv | Separable capsule for sprinkling applications |
US20220046970A1 (en) * | 2018-07-12 | 2022-02-17 | International Flavors & Fragrances Inc. | Verbascoside and related compounds for sweetness enhancement |
Non-Patent Citations (2)
Title |
---|
QUYNH-MAI THI NGO 等: "Chemical constituents from the fruits of Ligustrum japonicum and their inhibitory effects on T cell activation", 《PHYTOCHEMISTRY》, vol. 2017, pages 148 * |
管兆国 等: "《沂州木瓜栽培与利用技术问答》", 31 August 2004, 北京:金盾出版社, pages: 7 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024007104A1 (zh) * | 2022-07-04 | 2024-01-11 | 国际香料和香精公司 | 用于增强甜味的新型吡喃葡萄糖苷组合物 |
Also Published As
Publication number | Publication date |
---|---|
MX2021000330A (es) | 2021-03-25 |
US20210251267A1 (en) | 2021-08-19 |
BR112021000310A2 (pt) | 2021-06-29 |
EP3820305A4 (en) | 2022-04-27 |
WO2020014601A1 (en) | 2020-01-16 |
EP3820305A1 (en) | 2021-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2012355414B2 (en) | Methods for using rebaudioside C as a flavor enhancer | |
US20120164083A1 (en) | Sweetness Enhancers Including Rebaudioside A or D | |
US11980211B2 (en) | Verbascoside and related compounds for sweetness enhancement | |
US20150272184A1 (en) | Naringenin and salts thereof for sweetness enhancement | |
US8609069B2 (en) | Rebaudioside C and its stereoisomers as natural product sweetness enhancers | |
CN106793810B (zh) | 用于选择性掩味的环己烷羧酸 | |
US20110224311A1 (en) | Natural Product Sweetness Enhancers | |
CN112384076A (zh) | 用于增强甜度的女贞甙酸及其衍生物 | |
CN110049688B (zh) | 用于掩味的新型组合物 | |
CN113163810A (zh) | 用于调节味道的愈伤酸组合物和方法 | |
CN113163815A (zh) | 用于调节味道的苎麻组合物和方法 | |
CN113166023B (zh) | 用于调节味道的癸二酸组合物和方法 | |
WO2024007104A1 (zh) | 用于增强甜味的新型吡喃葡萄糖苷组合物 | |
US20240000119A1 (en) | Megastigmane derivative compositions and methods for taste modulation | |
BR112021010470B1 (pt) | Artigo de consumo, e, método para realçar a doçura ou sensação bucal de um artigo de consumo | |
EP2880992A2 (en) | Rebaudioside C and its stereoisomers as natural product sweetness enhancers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |